Insight Molecular Diagnostics Inc — Quarterly Balance Sheet (NASDAQ:IMDX)

Financials

Total revenue 146 K1.52 M2.17 M543 K289 K 4.51 M Gross profit 50 K595 K1.32 M350 K139 K 2.41 M Operating expenses 13.56 M34.22 M8.12 M10.19 M11.19 M 63.73 M Selling/general/admin expenses 3.61 M3.76 M4.32 M4.11 M3.93 M 16.12 M Research & development 2.82 M2.26 M2.92 M3.28 M3.88 M 12.34 M Operating income 13.52 M33.63 M6.8 M9.84 M11.05 M 61.32 M Non-Operating Income, Total 22 K116 K128 K100 K194 K 538 K Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses -31 K-30 K-29 K-25 K-29 K -113 K Unusual income/expense 53 K146 K157 K125 K223 K 651 K Pretax income 13.49 M33.51 M6.93 M9.94 M11.24 M 61.62 M Equity in earnings ————— — Taxes —0000 0 Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 13.49 M33.51 M6.67 M9.74 M10.85 M 60.78 M Discontinued operations 00——— — Net income 13.49 M33.51 M6.67 M9.74 M10.85 M 60.78 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 13.49 M33.51 M6.67 M9.74 M10.85 M 60.78 M Basic earnings per share (Basic EPS) -0.98-2.19-0.26-0.3-0.34 -3.09 Diluted earnings per share (Diluted EPS) -0.98-2.19-0.26-0.3-0.34 -3.09 Average basic shares outstanding 13.71 M13.07 M25.69 M32.02 M32.03 M 102.82 M Diluted shares outstanding 13.71 M13.07 M25.69 M32.02 M32.03 M 102.82 M EBITDA -13.44 M-33.01 M-6.27 M-9.26 M-10.44 M -58.98 M EBIT -13.46 M-33.58 M-6.76 M-9.82 M-11.02 M -61.17 M Cost of revenue 43 K869 K806 K168 K121 K 1.96 M Other cost of goods sold 0———— — Depreciation & amortization (cash flow) 22 K563 K491 K559 K584 K 2.2 M